Share Options

RNS Number : 6979F
Alliance Pharma PLC
28 April 2011
 



For immediate release

28 April 2011

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Share Options

 

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 28 April 2011 it awarded the following options over ordinary shares of one pence each in the Company to certain Directors:

 

Name

Position

Number of share options awarded

Exercise price per share

Date of vesting

Percentage of issued ordinary share capital

Tony Booley

Executive Director  

130,000

34.12p

28 April 2014

0.05%

Peter Butterfield

 

Executive Director

1,130,000

34.12p

28 April 2014

0.48%

Richard Wright

Finance Director

130,000

34.12p

28 April 2014

0.05%

 

 

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive


Richard Wright, Finance Director




Buchanan Communications

+ 44 (0) 20 7466 5000

Mark Court / Jessica Fontaine




Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Simon Blank


Corporate Broking: David Poutney


 

Notes to editors:

 

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and, following the Cambridge Laboratories acquisition, owns or licenses the rights to more than 50 pharmaceutical products and continues to explore opportunities to expand the range.

 

Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections.  Alliance's sales are mainly prescription driven.  Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDKFDQPBKDDQB
UK 100